Proteomics in neuropsychiatric disorders

The International Journal of Neuropsychopharmacology
C Rohlff

Abstract

Assessing human cerebrospinal fluid (CSF) provides a practical way to conduct longitudinal molecular analyses of changes during the course of neurological disease. Integrated and parallel analyses of neurotransmitters, neuropeptides and proteins in CSF may reveal better insights into complex interaction of numerous cell types in the central nervous system (CNS) at an unprecedented level of complexity and detail. Intricate molecular fingerprints of CSF proteins may pinpoint multiple underlying pathogenic mechanisms as well as an acute and a chronic CNS disease component. Some of these changes may be mapped to altered protein expression patterns in clinically relevant cell populations with a causative or diagnostic disease link. A CNS proteome database of primary human CNS tissues may avoid ambiguities of experimental models and accelerate pre- and clinical development of more specific diagnostic and prognostic disease markers and new selective therapeutics.

Citations

Jun 18, 2002·Trends in Molecular Medicine·Sofia Avissar, Gabriel Schreiber
Feb 3, 2007·Journal of Proteome Research·Fatima W KhwajaErwin G Van Meir
Aug 16, 2006·Neuro-degenerative Diseases·Raimund HoffroggeArndt Rolfs
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Richard Mayeux
Jan 1, 2009·Mass Spectrometry Reviews·Martin H Maurer
May 14, 2003·Biological Psychiatry·Christian Rohlff, Kate Hollis
Apr 4, 2007·Mass Spectrometry Reviews·Anna DrabikJerzy Silberring

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.